Balchem (Nasdaq: BCPC) reported earnings on Nov. 2. Here are the numbers you need to know.

The 10-second takeaway
For the quarter ended Sep. 30 (Q3), Balchem missed estimates on revenues and beat expectations on earnings per share.

Compared to the prior-year quarter, revenue grew slightly and GAAP earnings per share was unchanged.

Gross margins grew, operating margins increased, net margins were steady.

Revenue details
Balchem reported revenue of $75.1 million. The three analysts polled by S&P Capital IQ predicted a top line of $77.4 million on the same basis. GAAP reported sales were 0.9% higher than the prior-year quarter's $74.4 million.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
EPS came in at $0.36. The three earnings estimates compiled by S&P Capital IQ forecast $0.35 per share. GAAP EPS of $0.36 were the same as the prior-year quarter.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
For the quarter, gross margin was 31.1%, 70 basis points better than the prior-year quarter. Operating margin was 21.6%, 120 basis points better than the prior-year quarter. Net margin was 14.5%, about the same as the prior-year quarter.

Looking ahead
Next quarter's average estimate for revenue is $73.7 million. On the bottom line, the average EPS estimate is $0.35.

Next year's average estimate for revenue is $306.4 million. The average EPS estimate is $1.33.

Investor sentiment
The stock has a five-star rating (out of five) at Motley Fool CAPS, with 356 members out of 366 rating the stock outperform, and 10 members rating it underperform. Among 83 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 82 give Balchem a green thumbs-up, and one give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Balchem is outperform, with an average price target of $37.00.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium advisory service. We’re motley! Questioning an investing thesis -- even one of our own -- helps us all think critically about investing and make decisions that help us become smarter, happier, and richer.